ArticleSmall (Weinheim an der Bergstrasse, Germany)2025
Site-Specific Polymer-Protein-Polymer Conjugates for the Preparation of Dual Responsive Multilayer Nanoparticles.
Article in Small (Weinheim an der Bergstrasse, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Oxygen-Tolerant Photo-Induced Miniaturized Accelerated Atom Transfer Radical Polymerization (OPTIMA-ATRP) for High-Throughput Synthesis of Polymer Bioconjugates.Angewandte Chemie (International ed. in English) · 2026Article
- Development and characterization of egg white protein-pullulan-pomegranate peel polyphenol composite films for berry fruits preservation.Food chemistry: X · 2025Article
- Site-Specific Polymer-Protein-Polymer Conjugates for the Preparation of Dual Responsive Multilayer Nanoparticles.Small (Weinheim an der Bergstrasse, Germany) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Protein-polymer-based materials demonstrate high potential in advanced applications. However, controlled combinations of multiple proteins and polymers to obtain multimaterial systems is limited due to the complexity of retaining protein structure and function and achieving high structural control for the polymers simultaneously. Here, the first combination of a rebridging agent and thiol-induced, light-activated controlled radical polymerization (TIRP) is introduced to directly enable site-specific conjugation of two different polymers to native proteins. Specifically, poly(N-isopropyacrylamide) (pNIPAM) is attached to bovine serum albumin (BSA), followed by incorporation of a new rebridging agent, and initiating a second TIRP to introduce a glycopolymer, giving highly defined pNIPAM-BSA-glycopolymer conjugates. Above the lower critical solution temperature (LCST), nanoparticles with a glycopolymer corona are formed. The addition of a glycan-specific lectin leads to the formation of a second protein corona and so-called multilayer nanoparticles. Depending on the sequence of stimuli, the particles can either undergo a step-wise or one-step disassembly. Furthermore, by controlling the ratio of binding/non-binding glycopolymers in the multilayer nanoparticles, either distinct nanoparticles or large clusters can be formed. Thus, dual-responsive multilayered polymer-protein nanoparticles are now accessible with controlled and programmable material properties such as assembly and disassembly while maintaining the protein's native structure and thus function.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.